Glutathione Injection Recall Expands as FDA and CDC Warn of Endotoxin Illness

Three Texas pharmacies have recalled compounded glutathione products sold as injectable liquids after testing found increased levels of bacterial endotoxins. The recalled products include glutathione injections, Myers Cocktail and Tri-Immune Boost.

Which pharmacies recalled injectable glutathione?

The recalls involve products from Victory Medical Center Pharmacy, Optimal Balance Pharmacy and Centric Compounding. The Centric Compounding recall, announced over the weekend, includes products marketed as Myers Cocktail and Tri-Immune Boost.

Symptoms linked to injectable glutathione exposure

Illnesses consistent with exposure to bacterial endotoxins have been reported after people received injectable glutathione. Symptoms may include fever, chills, severe headache, dizziness, nausea, vomiting, increased heart rate, changes in blood pressure, body aches, fatigue, symptoms similar to an allergic reaction, and signs of shock or sepsis-like conditions.

Patients hospitalized in multiple states

Reports of illness have come from Texas, Washington, Florida and New York, according to a warning from the CDC. At least three people who received intravenous glutathione have been hospitalized. One person became seriously ill and required intensive care, including treatment for shock and abnormal blood clotting, the CDC said.

The FDA said in its latest update that it continues to receive reports of illness. The CDC also indicated that more cases could be reported as the investigation continues.

FDA previously warned about glutathione infusions

The FDA noted that this is not the first time glutathione, a dietary supplement ingredient, has been used in an IV drip or injectable product. In 2019, the agency issued a similar warning about compounded sterile glutathione injectables after reports of endotoxin poisoning. At least two people were hospitalized in that case.